1-4 of 4
Diana Gaitini, MD
Close
Sort by
Journal Articles

Six Cycles of BEACOPP Tailored Based on Interim Scintigraphy Provide Favorable Outcome for Patients with Standard and Advanced Risk Hodgkin Lymphoma and Female Fertility Is Preserved: Results of a 10-Year Follow-up

Eldad J Dann, MD, Zeev Blumenfeld, MD, Rachel Bar-Shalom, MD, Irit Avivi, MD, Menachem Ben-Shachar, MD, Odelia Goor, MD, Diana Libster, MD, Diana Gaitini, MD, Jacob M. Rowe, MD, Ron Epelbaum, MD
Journal: Blood
Blood (2011) 118 (21): 1564.
https://doi.org/10.1182/blood.V118.21.1564.1564
Published: 2011
Journal Articles

Not All Positive Interim PET/CT Scans Are Reliably Predictive for Progression Free Survival in Hodgkin Lymphoma (HL) Patients. A Proposed Model for a Functional Scoring Scale.

Eldad J. Dann, MD, Ada Tamir, PhD, Ron Epelbaum, MD, Irit Avivi, MD, Menachem Ben-Shachar, MD, Diana Gaitini, MD, Jacob M. Rowe, MD, Rachel Bar-Shalom, MD
Journal: Blood
Blood (2008) 112 (11): 1452.
https://doi.org/10.1182/blood.V112.11.1452.1452
Published: 2008
Journal Articles

In Patients with Aggressive Non-Hodgkin Lymphoma Treated with CHOP Therapy the Rapidity of Early Response, as Determined by Residual FDG Uptake, Does Not Impact on the Overall Prognosis.

Eldad J. Dann, MD, Eyal Fuchs, Ada Tamir, PhD, Irit Avivi, MD, Diana Gaitini, MD, Ora Israel, MD, Jacob M. Rowe, MD, Rachel Bar-Shalom, MD
Journal: Blood
Blood (2007) 110 (11): 2328.
https://doi.org/10.1182/blood.V110.11.2328.2328
Published: 2007
Journal Articles

Early Interim Negative FDG-PET/CT Is a High Predictive Factor for Progression-Free Survival in Hodgkin Lymphoma.

Eldad J. Dann, MD, Rachel Bar-Shalom, MD, Ada Tamir, PhD, Nissim Haim, MD, Irit Avivi, MD, Diana Gaitini, MD, Menachem Ben-Shachar, MD, Ora Israel, MD, Jacob M. Rowe, MD, Ron Epelbaum, MD
Journal: Blood
Blood (2006) 108 (11): 4589.
https://doi.org/10.1182/blood.V108.11.4589.4589
Published: 2006